A retrospective, single center study analysing the incidence of hyperbilirubinemia in Chronis Hepatitis C Patients Treated With Protease Inhibitors
Latest Information Update: 22 Dec 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020